McCallum Stewart 4
4 · Recro Pharma, Inc. · Filed Jan 4, 2018
Insider Transaction Report
Form 4
McCallum Stewart
Chief Medical Officer
Transactions
- Award
Common Stock
2018-01-02+16,100→ 27,701 total - Award
Employee Stock Option (right to buy)
2018-01-02+32,200→ 32,200 totalExercise: $9.04Exp: 2028-01-02→ Common Stock (32,200 underlying)
Footnotes (2)
- [F1]All shares of common stock are represented by unvested restricted stock units that will vest in four equal annual installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
- [F2]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.